NYSE American - BOATS Real Time Price
USD
BiomX Inc. (PHGE)
1.9700
+0.0400
(+2.07%)
At close: April 16 at 4:00:00 PM EDT
1.8100
-0.1600
(-8.12%)
Overnight: 2:28:58 AM EDT
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Loading chart for PHGE
Chart does not reflect overnight price.
- Previous Close
1.9300 - Open
1.9200 - Bid --
- Ask --
- Day's Range
1.9000 - 1.9800 - 52 Week Range
1.5000 - 14.7060 - Volume
1,271,361 - Avg. Volume
1,056,911 - Market Cap (intraday)
12.891M - Beta (5Y Monthly) 1.70
- PE Ratio (TTM)
-- - EPS (TTM)
-37.0500 - Earnings Date (est.) Apr 17, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
304.00
BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company's phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc. was founded in 2015 and is based in Dover, Delaware.
www.biomx.comRecent News: PHGE
View More
Performance Overview: PHGE
Trailing total returns as of 4/16/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
PHGE
5.35%
S&P 500 (^GSPC)
2.86%
1-Year Return
PHGE
80.80%
S&P 500 (^GSPC)
33.47%
3-Year Return
PHGE
96.26%
S&P 500 (^GSPC)
70.18%
5-Year Return
PHGE
99.84%
S&P 500 (^GSPC)
68.23%
Earnings Trends: PHGE
View MoreAnalyst Insights: PHGE
View MoreStatistics: PHGE
View MoreValuation Measures
As of 4/16/2026
-
Market Cap
12.89M
-
Enterprise Value
31.17M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
19.39
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-78.85%
-
Return on Equity (ttm)
-316.90%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-36.2M
-
Diluted EPS (ttm)
-37.0500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
4.36M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-14.07M
Compare To: PHGE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: PHGE
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
